Markets
Rivian Reveals All-Electric R2 Midsize SUV
(Phillip Faraone/Getty Images)

Rivian shares poised for best day since January as the EV maker hypes its next SUV during earnings call

Rivian shares surged more than 15% the morning following its Q3 earnings results.

Max Knoblauch

Rivian is on pace to record its second-best trading day of the year. The EV maker’s shares rose more than 15% in Wednesday morning trading following its third-quarter results, which dropped after market close on Tuesday.

The company posted a top- and bottom-line beat for Q3, including a nearly 80% sales spike year over year, and reaffirmed its guidance for full-year earnings and deliveries. That, along with an earnings call flush with hype for Rivian’s upcoming midsize SUV, the R2, appears to have investors excited.

“Were very, very bullish on what were building with R2. The way we think about it as a team is were building the best car you can buy in this category and in this price point,” CEO RJ Scaringe said on the company’s call with investors Tuesday evening.

Scaringe pitched the R2, which will be priced in the “$45,000 to $50,000 range,” as a direct competitor to Tesla’s Model 3 and Model Y. The company reaffirmed that it anticipates R2 production costs to come in at half of the R1’s.

“At this mass market price point... theres really been a single dominant brand with really two products. Thats of course Tesla with the Model 3 and the Model Y,” Scaringe said. “And with them taking up roughly half the market, 50% market share, its not a reflection of a healthy market. Its a reflection of a very underserved market in terms of choice and options.”

Rivian, which has been working to cut costs ahead of mass production of the R2, said it will devote nearly three-quarters of its Normal, Illinois, plant to building the vehicle. Its future Georgia plant will eventually support further production of the R2 and future vehicles, which are “architected... and designed from the very beginning contemplating Europe and planning for Europe.”

Rivian said the R2 is still on track to launch in the first half of 2026. “We would steer folks to there being limited volumes in the first half of the year. And then the second half of the year, well build up our ramp and see increasing production volumes,” said CFO Claire McDonough.

More Markets

See all Markets
markets

Health insurance stocks lose steam as Trump says he’ll lobby insurers for lower prices

Shares of health insurance companies dropped Friday afternoon, as President Trump said he would ask insurers to meet with him in the coming weeks to seek lower prices.

Stocks including Humana, UnitedHealthcare, Cigna, CVS Health, and Elevance Health all either pared gains or went further into the red after Trump’s remarks, which came at the end of a press event to announce pricing deals with nine drugmakers.

“I’m going to call a meeting of the big insurance companies that have gotten so rich,” Trump said, noting that he would lobby them for lower prices.

“I would say that maybe with one talk, they would be willing to cut their prices by 50, 60, or 70%. They’ve made a fortune.”

markets

Rivian’s surge continues as stock reaches highest level since December 2023 on analyst upgrades

Shares of EV maker Rivian are on pace to close up double digits for the second day in a row on Friday as bullish investors pour into the stock following analyst upgrades.

Rivian shares were up more than 10% on Friday afternoon, with the stock climbing to its highest level since December 2023.

Webush’s Dan Ives boosted his Rivian price target by 56% to $25 in a note on Friday morning. The analyst wrote that 2026 is a “prove-me” year for the automaker, with its lower-cost R2 model set to launch in the first half.

Ives’s note follows a separate optimistic bit of analysis from Baird, which also boosted its Rivian price target to $25 in a note on Thursday.

If today's gains hold, Friday will mark the third day of double-digit gains for Rivian in the past six trading days. An “AI Day” event that saw the automaker detail autonomous updates and tease a robotaxi plan started the recent run.

markets

The neoclouds are shooting back up into the stratosphere

Investors’ faith in tech CEOs’ pursuit of digital God has seemingly been restored for now, sparking an intense rally in the speculative AI players that had been in full-on meltdown mode over concerns that the boom had passed its best-before date.

The data center companies colloquially known as the “neoclouds” — CoreWeave, Nebius, IREN, and Cipher Mining — are up more than double digits over the past two sessions, as of 10:40 a.m. ET.

The past 48 hours have brought a steady drumbeat of positive news for the AI theme.

CoreWeave received a vote of confidence from Wall Street as Citi resumed coverage with a buy rating and price target of $135. Oracle, the epicenter of AI credit concerns, has seen a reversal in its fortunes as it nears an acquisition of TikTok’s US operations. And OpenAI’s fundraising efforts appear be going so well that its reported valuation has gone up in back-to-back days.

Before that, Micron’s earnings reaffirmed the intense demand for AI compute, which continues to outstrip supply — a positive sign for the neoclouds. The macro backdrop is also turning perhaps a bit more in favor of lower interest rates, as CPI inflation came in well below expectations.

Snoop Dogg Performs At OVO Hydro Glasgow

Marijuana rescheduling could mean more investment in US weed stocks. There aren’t many ways in.

“Yes, institutional capital will go into the underlying names. The question is: How fast?" one weed company chairman said.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.